1sec.ai

Tag

#drug-discovery

Every item tagged drug-discovery, newest first.

3 items

Using AI to improve a challenging reaction in medicinal chemistry

Researchers used OpenAI's technology to improve a challenging reaction in medicinal chemistry. The AI system generated novel molecules and reaction conditions that led to a 72% increase in reaction yield. This demonstrates the potential for AI to accelerate drug discovery.

Key takeaways
  • 72% increase in reaction yield achieved.
  • AI generated novel molecules and reaction conditions.
  • Improves drug discovery process.

TxBench-PP: Analyzing AI Agent Performance on Small-Molecule Preclinical Pharmacology

Researchers introduced TxBench-PP, a benchmark for evaluating AI agents in small-molecule preclinical pharmacology. It provides a standardized way to assess AI performance in drug discovery, focusing on realistic program decisions. The benchmark aims to facilitate trusted evaluation and deployment of AI agents in this field. You can use TxBench-PP to compare AI models and improve their performance in drug discovery.

Key takeaways
  • TxBench-PP is a benchmark for small-molecule preclinical pharmacology.
  • It tests AI agents on realistic program decisions in drug discovery.
  • The benchmark aims to enable trusted evaluation and deployment of AI agents.
otherSep 2

SAIR: Accelerating Pharma R&D with AI-Powered Structural Intelligence

SandboxAQ and Hugging Face collaborated on SAIR, an AI-powered structural intelligence platform for pharma R&D. SAIR accelerates drug discovery by combining AI with experimental data. You can explore SAIR's capabilities and datasets on the Hugging Face Hub.

Key takeaways
  • SAIR combines AI and experimental data for pharma R&D.
  • Accelerates drug discovery with structural intelligence.
  • Available on Hugging Face Hub.